Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02205333 |
Title | A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies |
Acronym | MEDI6469 |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | MedImmune LLC |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Research Site | Scottsdale | Arizona | 85259 | United States | Details | |
Research Site | Sacramento | California | 95817 | United States | Details | |
Research Site | Santa Monica | California | 90404 | United States | Details | |
Research Site | Washington, D.C. | District of Columbia | 20007 | United States | Details | |
Research Site | Tampa | Florida | 33612 | United States | Details | |
Research Site | Chicago | Illinois | 60611 | United States | Details | |
Research Site | Detroit | Michigan | 48202 | United States | Details | |
Research Site | Las Vegas | Nevada | 89169 | United States | Details | |
Research Site | Hackensack | New Jersey | 7601 | United States | Details | |
Research Site | Huntersville | North Carolina | 28078 | United States | Details | |
Research Site | Portland | Oregon | 97213 | United States | Details | |
Research Site | Memphis | Tennessee | 38120 | United States | Details | |
Research Site | Houston | Texas | 77030 | United States | Details |